# FACBC for Recurrent Prostate Cancer

> **NCT01808222** · PHASE2 · COMPLETED · sponsor: **David M. Schuster, MD** · enrollment: 25 (actual)

## Conditions studied

- Recurrent Prostate Cancer

## Interventions

- **DRUG:** FACBC

## Key facts

- **NCT ID:** NCT01808222
- **Lead sponsor:** David M. Schuster, MD
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-11
- **Primary completion:** 2017-09-13
- **Final completion:** 2017-09-13
- **Target enrollment:** 25 (ACTUAL)
- **Last updated:** 2019-01-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01808222

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01808222, "FACBC for Recurrent Prostate Cancer". Retrieved via AI Analytics 2026-06-11 from https://api.ai-analytics.org/clinical/NCT01808222. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*